Sacral nerve stimulation (SNS) is a minimally invasive procedure that involves placing a small medical device called an implantable neurostimulator to treat bladder, bowel, and pelvic floor disorders.
There are two types of sacral nerve stimulation systems - tined lead and paddle lead systems. Tined lead systems involve the insertion of a thin wire with tiny electrodes at the tip, called a lead, through the skin into the S3 sacral foramen area under imaging guidance. The lead is then attached to an internal pulse generator which is implanted in the lower butt area. Paddle lead systems involve surgically placing a lead with a flat, soft paddle at its tip which sits directly on the sacral nerve.
Both systems work by sending mild electrical pulses to the sacral nerves that control bowel and bladder function. This disrupts the abnormal signals causing symptoms and restores normal function. Sacral nerve stimulation has shown significant success in improving symptoms of overactive bladder, fecal incontinence, and chronic pelvic pain. Some advantages include being minimally invasive, with a adjustable therapy that can be turned on or off, byproviding improvements within days of being turned on. However, the implants do require permanent surgical placement and eventual battery replacement surgery. There is also a chance of leads moving out of optimal position long-term.
Market Dynamics:
Global sacral nerve stimulation market is mainly driven by the increasing prevalence of chronic devices. For instance, according to the data published by the National Center for Biotechnology Information (NCBI) in December 2018, the global chronic pain prevalence survey found that 19.3% Indian adult population suffers from cerebral palsy.
Key features of the study:
Detailed Segmentation:
Table of Contents
*Browse 44 market data tables and 37 figures on “Global Sacral Nerve Stimulation Market” - Global forecast to 2030
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients